Myers JA, Miller JS. Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol. 2021;18:85–100.
Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337–41.
Article CAS PubMed PubMed Central Google Scholar
Rustenhoven J, Drieu A, Mamuladze T, de Lima KA, Dykstra T, et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell. 2021;184:1000–16.e27.
Article CAS PubMed PubMed Central Google Scholar
Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat Immunol. 2017;18:123–31.
Article CAS PubMed Google Scholar
Mujal AM, Delconte RB, Sun JC. Natural killer cells: from innate to adaptive features. Annu Rev Immunol. 2021;39:417–47.
Article CAS PubMed Google Scholar
Shimasaki N, Jain A, Campana D. NK cells for cancer immunotherapy. Nat Rev Drug Discov. 2020;19:200–18.
Article CAS PubMed Google Scholar
Freud AG, Mundy-Bosse BL, Yu J, Caligiuri MA. The broad spectrum of human natural killer cell diversity. Immunity. 2017;47:820–33.
Article CAS PubMed PubMed Central Google Scholar
Abel AM, Yang C, Thakar MS, Malarkannan S. Natural killer cells: development, maturation, and clinical utilization. Front Immunol. 2018;9:1869.
Article PubMed PubMed Central Google Scholar
Björkström NK, Strunz B, Ljunggren H-G. Natural killer cells in antiviral immunity. Nat Rev Immunol. 2021;22:112–23.
Article PubMed PubMed Central Google Scholar
Chan A, Hong DL, Atzberger A, Kollnberger S, Filer AD, et al. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol. 2007;179:89–94.
Article CAS PubMed Google Scholar
Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, et al. Innate lymphoid cells: 10 years on. Cell. 2018;174:1054–66.
Article CAS PubMed Google Scholar
Sun H, Sun C, Xiao W, Sun R. Tissue-resident lymphocytes: from adaptive to innate immunity. Cell Mol Immunol. 2019;16:205–15.
Article CAS PubMed PubMed Central Google Scholar
Peng H, Tian Z. Diversity of tissue-resident NK cells. Semin Immunol. 2017;31:3–10.
Article CAS PubMed Google Scholar
Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol. 2006;6:520–31.
Article CAS PubMed Google Scholar
Boudreau JE, Hsu KC. Natural killer cell education and the response to infection and cancer therapy: stay tuned. Trends Immunol. 2018;39:222–39.
Article CAS PubMed PubMed Central Google Scholar
Shifrin N, Raulet DH, Ardolino M. NK cell self tolerance, responsiveness and missing self recognition. Semin Immunol. 2014;26:138–44.
Article CAS PubMed PubMed Central Google Scholar
Gasser S, Raulet DH. Activation and self-tolerance of natural killer cells. Immunol Rev. 2006;214:130–42.
Article CAS PubMed Google Scholar
Gianchecchi E, Delfino DV, Fierabracci A. NK cells in autoimmune diseases: Linking innate and adaptive immune responses. Autoimmun Rev. 2018;17:142–54.
Article CAS PubMed Google Scholar
Fehniger TA. Mystery solved: IL-15. J Immunol. 2019;202:3125–6.
Article CAS PubMed Google Scholar
Becknell B, Caligiuri MA. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol. 2005;86:209–39.
Article CAS PubMed Google Scholar
Lee GA, Lin TN, Chen CY, Mau SY, Huang WZ, et al. Interleukin 15 blockade protects the brain from cerebral ischemia-reperfusion injury. Brain Behav Immun. 2018;73:562–70.
Article CAS PubMed Google Scholar
Konjević GM, Vuletić AM, Mirjačić Martinović KM, Larsen AK, Jurišić VB. The role of cytokines in the regulation of NK cells in the tumor environment. Cytokine. 2019;117:30–40.
Wu Y, Tian Z, Wei H. Developmental and functional control of natural killer cells by cytokines. Front Immunol. 2017;8:930.
Article PubMed PubMed Central Google Scholar
Zwirner NW, Ziblat A. Regulation of NK cell activation and effector functions by the IL-12 family of cytokines: the case of IL-27. Front Immunol. 2017;8:25.
Article PubMed PubMed Central Google Scholar
Fu B, Tian Z, Wei H. Subsets of human natural killer cells and their regulatory effects. Immunology. 2014;141:483–9.
Article CAS PubMed PubMed Central Google Scholar
Pinto S, Pahl J, Schottelius A, Carter PJ, Koch J. Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagers. Trends Immunol. 2022;43:932–46.
Article CAS PubMed Google Scholar
Dogra P, Rancan C, Ma W, Toth M, Senda T, et al. Tissue determinants of human NK cell development, function, and residence. Cell. 2020;180:749–63.e13.
Article CAS PubMed PubMed Central Google Scholar
Korin B, Ben-Shaanan TL, Schiller M, Dubovik T, Azulay-Debby H, et al. High-dimensional, single-cell characterization of the brain’s immune compartment. Nat Neurosci. 2017;20:1300–9.
Article CAS PubMed Google Scholar
Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48:380–95.e6.
Article CAS PubMed Google Scholar
Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol. 2006;176:1517–24.
Article CAS PubMed Google Scholar
Gross CC, Schulte-Mecklenbeck A, Rünzi A, Kuhlmann T, Posevitz-Fejfár A, et al. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation. Proc Natl Acad Sci U S A. 2016;113:E2973–82.
Article CAS PubMed PubMed Central Google Scholar
Schafflick D, Xu CA, Hartlehnert M, Cole M, Schulte-Mecklenbeck A, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247.
Article CAS PubMed PubMed Central Google Scholar
Lepennetier G, Hracsko Z, Unger M, Van Griensven M, Grummel V, et al. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases. J Neuroinflammation. 2019;16:219.
Article CAS PubMed PubMed Central Google Scholar
Gan Y, Liu R, Wu W, Bomprezzi R, Shi FD. Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2012;247:9–15.
Article CAS PubMed PubMed Central Google Scholar
Yao X, Matosevic S. Chemokine networks modulating natural killer cell trafficking to solid tumors. Cytokine Growth Factor Rev. 2021;59:36–45.
Article CAS PubMed Google Scholar
Huang D, Shi FD, Jung S, Pien GC, Wang J, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 2006;20:896–905.
Comments (0)